Novel instantly-dispersible nanocarrier powder system (IDNPs) for intranasal delivery of dapoxetine hydrochloride: in-vitro optimization, ex-vivo permeation studies, and in-vivo evaluation

References

• Mohee A, Eardley I. Medical therapy for premature ejaculation. Ther Adv Urol. 2011;3:211–222.
   PubMedGoogle Scholar
• McCarty E, Dinsmore W. Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation. Core Evid. 2012;7:1–14.
   PubMedGoogle Scholar
• Modi NB, Dresser MJ, Simon M, et al. Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation. J Clin Pharmacol. 2006;46:301–309.
   PubMed Web of Science ®Google Scholar
• McMahon CG. Dapoxetine: a new option in the medical management of premature ejaculation. Ther Adv Urol. 2012;4:233–251.
   PubMedGoogle Scholar
• Andersson KE, Mulhall JP, Wyllie MG. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation. BJU Int. 2006;97:311–315.
   PubMed Web of Science ®Google Scholar
• Srikant P, Mahesh S, Akash J, et al. Formulation development and evaluation of dapoxetine hydrochloride tablets approved for the treatment of premature ejaculation. Int J Pharm Sci Rev Res. 2014;26:328–332.
   Google Scholar
• Turkyilmaz A, Gulay Y. Novel effervescent sachet formulations of dapoxetine and a PDE5 inhibitor. US patent 2015/0231092A1.
   Google Scholar
• Fouad SA, Shamma RN, Basalious EB, et al. Novel instantly-soluble transmucosal matrix (ISTM) using dual mechanism solubilizer for sublingual and nasal delivery of dapoxetine hydrochloride: in-vitro/in-vivo evaluation. Int J Pharm. 2016;505:212–222.
   PubMed Web of Science ®Google Scholar
• Huh Y, Cho HJ, Yoon IS, et al. Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochloride. Eur J Pharm Sci. 2010;40:9–15.
   PubMed Web of Science ®Google Scholar
• Piao HM, Balakrishnan P, Cho HJ, et al. Preparation and evaluation of fexofenadine microemulsions for intranasal delivery. Int J Pharm. 2010;395:309–316.
   PubMed Web of Science ®Google Scholar
• Hussain A, Foster T, Hirai S, et al. Nasal absorption of propranolol in humans. J Pharm Sci. 1980;69:1240.
   PubMed Web of Science ®Google Scholar
• Zaki NM, Awad GA, Mortada ND, et al. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci. 2007;32:296–307.
   PubMed Web of Science ®Google Scholar
• Costantino HR, Illum L, Brandt G, et al. Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm. 2007;337:1–24.
   PubMed Web of Science ®Google Scholar
• Luo Y, Chen D, Ren L, et al. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release. 2006;114:53–59.
   PubMed Web of Science ®Google Scholar
• Soliman GM, Sharma R, Choi AO, et al. Tailoring the efficacy of nimodipine drug delivery using nanocarriers based on A2B miktoarm star polymers. Biomaterials. 2010;31:8382–8392.
   PubMed Web of Science ®Google Scholar
• Chandrasekhar R, Hassan Z, Alhusban F, et al. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets. Eur J Pharm Biopharm. 2009;72:119–129.
   PubMed Web of Science ®Google Scholar
• Cevc G, Gebauer D, Stieber J, et al. Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta. 1998;1368:201–215.
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta. 2004;1663:61–73.
   PubMed Web of Science ®Google Scholar
• Hiruta Y, Hattori Y, Kawano K, et al. Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin. J Control Release. 2006;113:146–154.
   PubMed Web of Science ®Google Scholar
• Pisal SS, Paradkar AR, Mahadik KR, et al. Pluronic gels for nasal delivery of Vitamin B12. Part I: preformulation study. Int J Pharm. 2004;270:37–45.
   PubMed Web of Science ®Google Scholar
• Escobar-Chavez JJ, López-Cervantes M, Naïk A, et al. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci. 2006;9:339–358.
   PubMed Web of Science ®Google Scholar
• Chen D, Xia D, Li X, et al. Comparative study of Pluronic((R)) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats. Int J Pharm. 2013;449:1–9.
   PubMed Web of Science ®Google Scholar
• Dai Y, Zhou R, Liu L, et al. Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. Int J Nanomedicine. 2013;8:1921–1933.
   PubMed Web of Science ®Google Scholar
• Abdelbary AA, AbouGhaly MH. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm. 2015;485:235–243.
   PubMed Web of Science ®Google Scholar
• Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm. 2010;391:203–211.
   PubMed Web of Science ®Google Scholar
• Abdelbary G. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm Dev Technol. 2011;16:44–56.
   PubMed Web of Science ®Google Scholar
• Salama HA, Mahmoud AA, Kamel AO, et al. Brain delivery of olanzapine by intranasal administration of transfersomal vesicles. J Liposome Res. 2012;22:336–345.
   PubMed Web of Science ®Google Scholar
• Scognamiglio I, De Stefano D, Campani V, et al. Nanocarriers for topical administration of resveratrol: a comparative study. Int J Pharm. 2013;440:179–187.
   PubMed Web of Science ®Google Scholar
• Guidance for Industry. Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Food and Drug Administration (USA). Center for Drug Evaluation and Research (CDER); July 2005.
   Google Scholar
• Salama HA, Mahmoud AA, Kamel AO, et al. Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route. Colloids Surf B Biointerfaces. 2012;100:146–154.
   PubMed Web of Science ®Google Scholar
• Hao Y, Zhao F, Li N, et al. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm. 2002;244:73–80.
   PubMed Web of Science ®Google Scholar
• Abdelbary G, El-Gendy N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech. 2008;9:740–747.
   PubMed Web of Science ®Google Scholar
• Rowe R, Sheskey PJ, Owen SC et al., editors. Handbook of pharmaceutical excipients. 6th ed. London; Chicago: APhA/Pharmaceutical Press; 2009.
   Google Scholar
• Das S, Ng WK, Tan RB. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci. 2012;47:139–151.
   PubMed Web of Science ®Google Scholar
• Basha M, Abd El-Alim SH, Shamma RN, et al. Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole. J Liposome Res. 2013;23:203–210.
   PubMed Web of Science ®Google Scholar
• Dora CP, Singh SK, Kumar S, et al. Development and characterization of nanoparticles of glibenclamide by solvent displacement method. Acta Pol Pharm. 2010;67:283–290.
   PubMed Web of Science ®Google Scholar
• van den Bergh BA, Wertz PW, Junginger HE, et al. Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int J Pharm. 2001;217:13–24.
   PubMed Web of Science ®Google Scholar
• Aburahma MH, Abdelbary GA. Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation. Int J Pharm. 2012;422:139–150.
   PubMed Web of Science ®Google Scholar
• Muller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev. 2001;47:3–19.
   PubMed Web of Science ®Google Scholar
• Shamma RN, Elsayed I. Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization. J Liposome Res. 2013;23:244–254.
   PubMed Web of Science ®Google Scholar
• Varma MVS, Ashokraj Y, Dey CS, et al. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res. 2003;48:347–359.
   PubMed Web of Science ®Google Scholar
• Wei Z, et al. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm. 2009;376:176–185.
   PubMed Web of Science ®Google Scholar
• Holm R, Jensen IH, Sonnergaard J. Optimization of self-microemulsifying drug delivery systems (SMEDDS) using a D-optimal design and the desirability function. Drug Dev Ind Pharm. 2006;32:1025–1032.
   PubMed Web of Science ®Google Scholar
• Al-Mahallawi AM, Abdelbary AA, Aburahma MH. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. Int J Pharm. 2015;485:329–340.
   PubMed Web of Science ®Google Scholar
• El Zaafarany GM, Awad GA, Holayel SM, et al. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 2010;397:164–172.
   PubMed Web of Science ®Google Scholar
• Shokri J, Nokhodchi A, Dashbolaghi A, et al. The effect of surfactants on the skin penetration of diazepam. Int J Pharm. 2001;228:99–107.
   PubMed Web of Science ®Google Scholar
• Shoukri RA, Ahmed IS, Shamma RN. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Eur J Pharm Biopharm. 2009;73:162–171.
   PubMed Web of Science ®Google Scholar